Michael D Stein1,2, Olga J Santiago Rivera3, Bradley J Anderson2, Genie L Bailey4,5. 1. Health Law, Policy & Management, Boston University School of Public Health, Boston, Massachusetts. 2. Butler Hospital, Providence, Rhode Island. 3. Department of Psychology, Michigan State University, East Lansing, Michigan. 4. Stanley Street Treatment and Resources, Inc., Fall River, Massachusetts. 5. Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Abstract
BACKGROUND AND OBJECTIVES: Depression is common among persons with opioid use disorder. We examined the perceived need for depression treatment (PNDT) among opioid-dependent patients and the relationship of PNDT to depression screening result. METHODS: Between May and December 2015, we surveyed consecutive persons (n = 440) seeking inpatient opioid detoxification. We used the Patient Health Questionnaire-2 (PHQ-2) to screen for depression. To assess perceived need for depression services, participants were asked, "Do you believe you should be treated for depression?" Response options were recorded into four categories: "Not Depressed (ND)," "Perceive Need for Depression Treatment (PNDT)," "Depressed/Don't Want Treatment," and "Currently Treated." RESULTS: Participants' mean age was 32.3 (±8.7) years; 70.7% were male. Nearly two out of three persons screened positive for depression yet only 8.2% were being treated for depression prior to admission. Screening positive for depression was associated with a 2.95 (95%CI 1.82-4.81, p < .005) fold increase in the expected odds of PNDT. But nearly half of those depressed (48%) did not perceive the need for treatment. Approximately 40% of the participants (n = 177) perceived that they were not depressed; of these persons, 52% screened positive for depression. DISCUSSION AND CONCLUSIONS: Detoxification program staff should screen patients for depression, and if a clinical diagnosis is confirmed, discuss treatment options, exploring the level of interest in mental health treatment for depression. SCIENTIFIC SIGNIFICANCE: Screening for and addressing depression, including patients' interest in treatment, should be central to post-detoxification aftercare planning. (Am J Addict 2017;26:395-399).
BACKGROUND AND OBJECTIVES:Depression is common among persons with opioid use disorder. We examined the perceived need for depression treatment (PNDT) among opioid-dependent patients and the relationship of PNDT to depression screening result. METHODS: Between May and December 2015, we surveyed consecutive persons (n = 440) seeking inpatient opioid detoxification. We used the Patient Health Questionnaire-2 (PHQ-2) to screen for depression. To assess perceived need for depression services, participants were asked, "Do you believe you should be treated for depression?" Response options were recorded into four categories: "Not Depressed (ND)," "Perceive Need for Depression Treatment (PNDT)," "Depressed/Don't Want Treatment," and "Currently Treated." RESULTS:Participants' mean age was 32.3 (±8.7) years; 70.7% were male. Nearly two out of three persons screened positive for depression yet only 8.2% were being treated for depression prior to admission. Screening positive for depression was associated with a 2.95 (95%CI 1.82-4.81, p < .005) fold increase in the expected odds of PNDT. But nearly half of those depressed (48%) did not perceive the need for treatment. Approximately 40% of the participants (n = 177) perceived that they were not depressed; of these persons, 52% screened positive for depression. DISCUSSION AND CONCLUSIONS: Detoxification program staff should screen patients for depression, and if a clinical diagnosis is confirmed, discuss treatment options, exploring the level of interest in mental health treatment for depression. SCIENTIFIC SIGNIFICANCE: Screening for and addressing depression, including patients' interest in treatment, should be central to post-detoxification aftercare planning. (Am J Addict 2017;26:395-399).
Authors: Jumi Hayaki; Michael D Stein; Joanna A Lassor; Debra S Herman; Bradley J Anderson Journal: Drug Alcohol Depend Date: 2005-04-04 Impact factor: 4.492
Authors: Michael D Stein; Debra S Herman; Malyna Kettavong; Patricia A Cioe; Peter D Friedmann; Tahir Tellioglu; Bradley J Anderson Journal: J Subst Abuse Treat Date: 2010-07-03
Authors: Lidia Z Meshesha; Judith I Tsui; Jane M Liebschutz; Denise Crooks; Bradley J Anderson; Debra S Herman; Michael D Stein Journal: Addict Behav Date: 2013-08-14 Impact factor: 3.913
Authors: Rosemarie Kobau; Marc A Safran; Matthew M Zack; David G Moriarty; Daniel Chapman Journal: Health Qual Life Outcomes Date: 2004-07-30 Impact factor: 3.186
Authors: Jennifer D Ellis; Jill A Rabinowitz; Jonathan Wells; Fangyu Liu; Patrick H Finan; Michael D Stein; Denis G Antoine Ii; Gregory J Hobelmann; Andrew S Huhn Journal: J Affect Disord Date: 2021-12-04 Impact factor: 4.839